87 related articles for article (PubMed ID: 18555904)
1. Early combined immunosuppression in Crohn's disease.
Herfarth H; Isaacs K
Lancet; 2008 Jun; 371(9629):1995-6; author reply 1996-7. PubMed ID: 18555904
[No Abstract] [Full Text] [Related]
2. [A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators].
Martreau P
Gastroenterol Clin Biol; 2000 Dec; 24(12):1243-4. PubMed ID: 11277090
[No Abstract] [Full Text] [Related]
3. [Top-down versus Step-Up: new strategies in the treatment of Crohn's disease].
Meier J; Sturm A
Z Gastroenterol; 2009 Feb; 47(2):240-2. PubMed ID: 19197829
[No Abstract] [Full Text] [Related]
4. Thalidomide improves clinical remission in children with Crohn's disease.
Harbour S; Brown N
Arch Dis Child Educ Pract Ed; 2015 Apr; 100(2):111. PubMed ID: 25721487
[No Abstract] [Full Text] [Related]
5. Early combined immunosuppression in Crohn's disease.
Badina L; Taddio A; Ventura A
Lancet; 2008 Jun; 371(9629):1995; author reply 1996-7. PubMed ID: 18555906
[No Abstract] [Full Text] [Related]
6. Optimum duration of treatment with 6-mercaptopurine for Crohn's disease.
Kim PS; Zlatanic J; Korelitz BI; Gleim GW
Am J Gastroenterol; 1999 Nov; 94(11):3254-7. PubMed ID: 10566725
[TBL] [Abstract][Full Text] [Related]
7. [Drug treatment of Crohn's disease].
van Deventer SJ; Tytgat GN
Ned Tijdschr Geneeskd; 1998 May; 142(21):1191-5. PubMed ID: 9627451
[TBL] [Abstract][Full Text] [Related]
8. A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators.
Feagan BG; Fedorak RN; Irvine EJ; Wild G; Sutherland L; Steinhart AH; Greenberg GR; Koval J; Wong CJ; Hopkins M; Hanauer SB; McDonald JW
N Engl J Med; 2000 Jun; 342(22):1627-32. PubMed ID: 10833208
[TBL] [Abstract][Full Text] [Related]
9. [Infliximab in the treatment of refractory gastroduodenal Crohn's disease].
Rodríguez-Grau Mdel C; Chaparro M; Díaz R; Gisbert JP
Gastroenterol Hepatol; 2014 Jan; 37(1):21-2. PubMed ID: 24029174
[No Abstract] [Full Text] [Related]
10. 6-Mercaptopurine in maintaining remission in Crohn's disease: An old friend becomes a new hero.
Seidman EG
Gastroenterology; 2000 Oct; 119(4):1158-60. PubMed ID: 11040202
[No Abstract] [Full Text] [Related]
11. Methotrexate: a useful alternative in Crohn's disease?
Hawthorne AB
Gut; 2001 Jul; 49(1):9-10. PubMed ID: 11413103
[No Abstract] [Full Text] [Related]
12. Methotrexate: the best choice for second-line maintenance treatment in active Crohn's disease?
Grimaldi C
Gastroenterol Clin Biol; 2009 Jan; 33(1 Pt 1):21-2. PubMed ID: 18977624
[No Abstract] [Full Text] [Related]
13. [Immunosuppressive treatment of Crohn's disease].
Kasper H; Auer I
Dtsch Z Verdau Stoffwechselkr; 1976; 36(3-4):143-5. PubMed ID: 1021382
[No Abstract] [Full Text] [Related]
14. The safety and tolerability of methotrexate for treating patients with Crohn's disease.
Chande N; Abdelgadir I; Gregor J
J Clin Gastroenterol; 2011 Aug; 45(7):599-601. PubMed ID: 21224737
[TBL] [Abstract][Full Text] [Related]
15. Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506).
Fellermann K; Ludwig D; Stahl M; David-Walek T; Stange EF
Am J Gastroenterol; 1998 Oct; 93(10):1860-6. PubMed ID: 9772045
[TBL] [Abstract][Full Text] [Related]
16. Immunosuppression in patients with Crohn's disease and neoplasia: an ongoing clinical dilemma.
Dasari BV; McBrearty A; Gardiner K
Dis Colon Rectum; 2012 Sep; 55(9):1008-11. PubMed ID: 22874610
[No Abstract] [Full Text] [Related]
17. Maintenance of remission in Crohn's disease.
Gonvers JJ; Juillerat P; Mottet C; Felley C; Burnand B; Vader JP; Michetti P; Froehlich F
Digestion; 2005; 71(1):41-8. PubMed ID: 15711049
[TBL] [Abstract][Full Text] [Related]
18. [Methotrexate an alternative for young persons with Crohn disease].
Hansson ME; Arebro J; Casswall T; Hessami M
Lakartidningen; 2011 Apr 13-19; 108(15):860-3. PubMed ID: 21674974
[No Abstract] [Full Text] [Related]
19. Thalidomide for the treatment of recalcitrant oral Crohn's disease and orofacial granulomatosis.
Hegarty A; Hodgson T; Porter S
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 May; 95(5):576-85. PubMed ID: 12738949
[TBL] [Abstract][Full Text] [Related]
20. Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease.
Peyrin-Biroulet L; Oussalah A; Williet N; Pillot C; Bresler L; Bigard MA
Gut; 2011 Jul; 60(7):930-6. PubMed ID: 21228429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
